Buscar en
Endocrinología y Nutrición
Toda la web
Inicio Endocrinología y Nutrición Utilidad del cortisol plasmático nocturno en el diagnóstico del síndrome de C...
Información de la revista
Vol. 48. Núm. 5.
Páginas 135-139 (Mayo 2001)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 48. Núm. 5.
Páginas 135-139 (Mayo 2001)
Acceso a texto completo
Utilidad del cortisol plasmático nocturno en el diagnóstico del síndrome de Cushing
Utility of nocturnal plasma cortisol in the diagnosis of cushing's syndrome
Visitas
9727
D. Marrero Arencibia1, A. Ojeda Pino1, Y. López Plasencia1, F.J. Novoa Mogollón1, M. Boronat Cortés
,
, M. Suárez Cabrera*
1 Sección de Endocrinología y Nutrición. Interna. Hospital
* Servicio de Medicina Universitario Insular. Las Palmas de Gran Canaria
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas

:La determinacion del cortisol plasmatico nocturno se ha propuesto como una alternativa en el diagnostico del sindrome de Cushing, principalmente para diferenciar entre pacientes con sindrome de Cushing y sujetos con estados de seudosindrome de Cushing.

:Se analizaron retrospectivamente las medidas de cortisol plasmatico a medianoche en 28 pacientes con sospecha clinica de sindrome de Cushing y elevacion de la excrecion de cortisol libre urinario (20 pacientes con sindrome de Cushing y 8 con seudosindrome de Cushing). No se realizaron estudios endocrinologicos el dia del ingreso. En los 2 dias posteriores se tomaron muestras para cortisol serico a las 8.00 y a las 24.00 h. Los resultados se compararon con otras pruebas diagnosticas realizadas simultaneamente (cortisol libre urinario y test de supresion con 1 mg de dexametasona).

El cortisol plasmatico a las 24.00 h fue el unico parametro que distinguio a todos los pacientes con sindrome de Cushing de aquellos con seudosindrome de Cushing. Su valor mas bajo entre los pacientes con sindrome de Cushing fue de 11,9 μg/dl, sin que se apreciaran diferencias entre los resultados obtenidos el segundo y el tercer dia de ingreso. En el grupo de pacientes con seudosindrome de Cushing, 3 casos presentaron un cortisol nocturno no suprimido durante el segundo dia de hospitalizacion (6,1–10,2 μg/dl), mientras que todas las determinaciones obtenidas 24 horas mas tarde proporcionaron valores menores de 5 μg/dl. Estos datos indican que el estudio del cortisol a medianoche puede requerir de un ingreso de al menos 48 h cuando se evalua a pacientes con seudosindrome de Cushing.

Palabras clave:
Síndrome de Cushing
Seudosíndrome de Cushing
Cortisol nocturno
Cortisol libre urinario

The determination of midnight plasma cortisol has been proposed as an alternative for the diagnosis of Cushing's syndrome, especially in order to differentiate patients with Cushing's syndrome from subjects with pseudo-Cushing's.

We retrospectively analysed the results of midnight cortisol measurements on 28 subjects with clinical suspicion of Cushing's syndrome and raised excretion of urinary free cortisol (20 patients with true Cushing's syndrome and 8 with pseudo-Cushing's states). No endocrine studies were carried out on the day of admission. Blood samples for serum cortisol assay were withdrawn at 8.00 and 24.00-h during the two following consecutive days. The results were compared to other laboratory investigations simultaneously performed (24 hours urinary free cortisol and overnight 1 mg dexamethasone suppression test).

Midnight cortisol was the only parameter that distinguished all patients with Cushing's syndrome from those with pseudo-Cushing's states. The lowest 24.00-h cortisol measured in a patient with Cushing's syndrome was 11.9 μg/dl and there were no differences between values obtained on either the second or the third day of hospital admission. In the pseudo-Cushing's group three cases showed unsuppressed midnight cortisol on the second day of hospitalisation (6.1–10.2 μg/dl), while cortisol concentrations were clearly blunted (< 5 (μg/dl) in all eight subjects when assessed 24 hours later. These data indicate that the measurement of midnight cortisol could require admission for at least 48 hours when patients with pseudo-Cushing syndrome are assessed.

Key words:
Cushing's syndrome
Cushing's pseudosyndrome
Night cortisol
Urinary free cortisol
El Texto completo está disponible en PDF
Biblografía
[1.]
J.C. Melby.
Assessment of adrenocortical function.
N Engl J Med, 285 (1971), pp. 735-739
[2.]
A.R. Glass, A.P. Zavadil III, F. Halberg, G. Cornelissen, M. Schaaf.
Circadian rhythm of serum cortisol in Cushing's disease.
J Clin Endocrinol Metab, 59 (1984), pp. 161-165
[3.]
S. Refetoff, E. Van Cauter, V.S. Fang, C. Laderman, M.L. Graybeal, R.L. Landau.
The effect of dexamethasone on the 24-hour profile of adrenocorticotropin and cortisol in Cushing's syndrome.
J Clin Endocrinol Metab, 60 (1985), pp. 527-535
[4.]
J. Newell-Price, P. Trainer, L. Perry, J. Wass, A. Grossman, M. Besser.
A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.
Clin Endocrinol (Oxf), 43 (1995), pp. 545-550
[5.]
D.A. Papanicolau, J.A. Yanovski, G.B. Cutler Jr, G.P. Chrousos, L.K. Nieman.
A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states.
J Clin Endocrinol Metab, 83 (1998), pp. 1163-1167
[6.]
R. Görges, G. Knappe, H. Gerl, M. Ventz, F. Stahl.
Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.
J Endocrinol Invest, 22 (1999), pp. 241-249
[7.]
M.H. Samuels, D.D. Brandon, L.M. Isabelle, D.M. Cook, K.E. Graham, J.Q. Purnell, et al.
Cortisol production rates in subjects with suspected Cushing's syndrome: assessment by stable isotope dilution methodology and comparison to other diagnostic methods.
J Clin Endocrinol Metab, 85 (2000), pp. 22-28
[8.]
C. Tsigos, G.P. Chrousos.
Physiology of the hypothalamic-pituitary-adrenal axis in health and dysregulation in psychiatric and autoimmune disorders.
Endocrinol Metab Clin North Am, 23 (1994), pp. 451-466
[9.]
J. Newell-Price, P. Trainer, M. Besser, A. Grossman.
The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.
Endocrin Rew, 19 (1998), pp. 647-672
[10.]
T. Mengden, P. Hubmann, J. Muller, P. Greminger, W. Vetter.
Urinary free cortisol vs 17-hydroxicorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome.
Clin Invest, 70 (1992), pp. 545-548
[11.]
D.N. Orth.
Cushing's syndrome.
N Engl J Med, 332 (1995), pp. 791-803
[12.]
J.W. Findling, H. Raff.
Newer diagnostic techniques and problems in Cushing's disease.
Endocrinol Metab Clin North Am, 28 (1999), pp. 191-210
[13.]
B.E. Pearson Murphy.
Lack of specificity of urinary free cortisol determinations: why does continue?.
J Clin Endocrinol Metab, 84 (1999), pp. 2258
[14.]
P.J. Wood, J.H. Barth, D.B. Freedman, L. Perry, B. Sheridan.
Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome-recommendations for a protocol for biochemistry laboratories.
Ann Clin Biochem, 34 (1997), pp. 222-229
[15.]
J. Montwill, D. Igoe, T.J. McKenna.
The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.
Steroids, 59 (1994), pp. 296-298
[16.]
J.A. Yanovski, G.B. Cutler, G.P. Chrousos, L.K. Nieman.
Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration.
JAMA, 269 (1993), pp. 2232-2238
[17.]
M. Duclos, J.B. Corcuff, P. Roger, A. Tabarin.
The dexamethasone-suppressed corticotrophin-releasing hormone stimulation test in anorexia nervosa.
Clin Endocrinol (Oxf), 51 (1999), pp. 725-731
Copyright © 2001. Sociedad Española de Endocrinología y Nutrición
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos